Biofrontera Statistics
Biofrontera (0DOL) Stock Statistics & Valuation Metrics
Total Valuation
Biofrontera has a market cap or net worth of EUR 16.83M. The enterprise value is EUR 11.99M.
- Market Cap
- EUR 16.83M
- Enterprise Value
- EUR 11.99M
Share Statistics
Biofrontera has 6,076,862 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 6,076,862
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Biofrontera’s return on equity (ROE) is -0.27 and return on invested capital (ROIC) is -6.58%.
- Return on Equity (ROE)
- -0.27
- Return on Assets (ROA)
- -0.19
- Return on Invested Capital (ROIC)
- -6.58%
- Return on Capital Employed (ROCE)
- -0.07
- Revenue Per Employee
- 212.73K
- Profits Per Employee
- -63.95K
- Employee Count
- 62
- Asset Turnover
- 0.64
- Inventory Turnover
- 0.61
Valuation Ratios
The current PE Ratio of Biofrontera is -1.48. Biofrontera’s PEG ratio is -0.01.
- PE Ratio
- -1.48
- PS Ratio
- 0.18
- PB Ratio
- -37.12
- Price to FCF
- -1.58
- Price to Operating Cash Flow
- -1.63
- PEG Ratio
- -0.01
Income Statement
In the last 12 months, Biofrontera had revenue of 13.19M and earned -3.96M in profits. Earnings per share was -0.65.
- Revenue
- 13.19M
- Gross Profit
- 10.91M
- Operating Income
- -1.02M
- Pretax Income
- -1.22M
- Net Income
- -3.96M
- EBITDA
- -560.00K
- Earnings Per Share (EPS)
- -0.65
Cash Flow
In the last 12 months, operating cash flow was 772.00K and capital expenditures 0, giving a free cash flow of 772.00K billion.
- Operating Cash Flow
- 772.00K
- Free Cash Flow
- 772.00K
- Free Cash Flow per Share
- -0.36
Dividends & Yields
Biofrontera pays an annual dividend of EUR 0.29, resulting in a dividend yield of ―
- Dividend Per Share
- EUR 0.29
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -65.20%
- Earnings Yield
- -70.11%
Stock Price Statistics
- Beta
- -0.50
- 52-Week Price Change
- -80.56%
- 50-Day Moving Average
- 2.98
- 200-Day Moving Average
- 2.92
- Relative Strength Index (RSI)
- 43.75
- Average Volume (3m)
- 273
Important Dates
Biofrontera upcoming earnings date is ―, TBA (Confirmed).
- Last Earnings Date
- Jun 03, 2026
- Next Earnings Date
- ―
- Ex-Dividend Date
- Mar 15, 2022
Financial Position
Biofrontera as a current ratio of 2.43, with Debt / Equity ratio of 4.20%
- Current Ratio
- 2.43
- Quick Ratio
- 1.77
- Debt to Market Cap
- 0.04
- Net Debt to EBITDA
- 5.32
- Interest Coverage Ratio
- -73.21
Taxes
In the past 12 months, Biofrontera has paid 5.72M in taxes.
- Income Tax
- 5.72M
- Effective Tax Rate
- -4.68
Enterprise Valuation
Biofrontera EV to EBITDA ratio is -2.40, with an EV/FCF ratio of -2.31.
- EV to Sales
- 0.27
- EV to EBITDA
- -2.40
- EV to Free Cash Flow
- -2.31
- EV to Operating Cash Flow
- -2.32
Balance Sheet
Biofrontera has EUR 3.08M in cash and marketable securities with EUR 1.15M in debt, giving a net cash position of EUR 1.93M billion.
- Cash & Marketable Securities
- EUR 3.08M
- Total Debt
- EUR 1.15M
- Net Cash
- EUR 1.93M
- Net Cash Per Share
- EUR 0.32
- Tangible Book Value Per Share
- EUR 0.30
Margins
Gross margin is 84.60%, with operating margin of -9.50%, and net profit margin of -12.72%.
- Gross Margin
- 84.60%
- Operating Margin
- -9.50%
- Pretax Margin
- -12.67%
- Net Profit Margin
- -12.72%
- EBITDA Margin
- -11.06%
- EBIT Margin
- -12.44%
Scores
- Smart Score
- 3
- AI Score
- ―

